The global companion diagnostics market is growing at a significant CAGR of around 12.8% during the forecast period (2020-2026). Companion diagnostics is referred to as in-vitro diagnostic device or an imaging tool that is used as a companion to a certain class of a therapeutic drug, to determine its relevancy to a patient. There are various pivotal factors that are driving the global companion diagnostic market, which includes increasing cases of adverse reactions to drugs, increasing demand for precision medicine, and continuous development of technologically advanced diagnostic techniques. In the recent past few years, a number of partnerships and collaborations are announced by the market players, such as
Get Free Sample link @ https://www.omrglobal.com/request-sample/companion-diagnostics-market
Moreover, a significant interest of government regulatory bodies can be seen in the companion diagnostics, which in turn, will drive fuel the market growth during the forecast period. For instance, in April 2020, the US FDA finalized the guidance that aimed at promoting broader labelling for companion diagnostics, to encourage precision oncology treatments across the globe. Such steps will promote the adoption of companion diagnostics across the globe. However, the unfavorable reimbursement policies will hamper the market growth during the forecast period.
A full report of Global Companion Diagnostics Market available @ https://www.omrglobal.com/report-customization/companion-diagnostics-market
- Market Coverage
- Market number available for – 2022-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered- By Source, By Product Type, By Applications
- Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc., and others
Market Segmentation
Global Companion Diagnostics Market by Technology
- Polymerase Chain Reaction (PCR)
- In Situ Hybridization (ISH)
- Immunohistochemistry (IHC)
- Next-Generation Sequencing (NGS)
- Others (Gene Sequencing)
Global Companion Diagnostics Market by Indication
- Breast Cancer
- Lung Cancer
- Melanoma
- Neurological Diseases
- Others (Gastric Cancer)
Regional Analysis
- North America
- United States
- Canada
- Europe
- UK
- Germany
- Italy
- Spain
- France
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- Rest of Asia-Pacific
- Rest of the World
Company Profiles
- Abbott Laboratories
- Abnova Corp.
- Agilent Technologies, Inc.
- Almac Group
- Amgen Inc.
- AstraZeneca PLC
- Biocartis NV
- bioMérieux SA
- Hoffmann-La Roche Ltd.
- Guardant Health, Inc.
- Illumina, Inc.
- Leica Biosystems
- Merck & Co., Inc.
- Myriad Genetics, Inc.
- Promega Corp.
- Protagen AG
- QIAGEN NV
- Siemens AG
- Sysmex Corp.
- Thermo Fisher Scientific Inc.
The Report Covers
- Market value data analysis of 2019 and forecast to 2026.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global companion diagnostics market. Based on the availability of data, information related to pipeline products, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/companion-diagnostics-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
